Mizuho Cuts Surgery Partners (NASDAQ:SGRY) Price Target to $17.00

Surgery Partners (NASDAQ:SGRY) had its target price decreased by Mizuho from $19.00 to $17.00 in a research note published on Thursday,Benzinga reports. Mizuho currently has an outperform rating on the stock.

Other analysts also recently issued reports about the company. Jefferies Financial Group reiterated a “buy” rating on shares of Surgery Partners in a research report on Wednesday. UBS Group dropped their price target on Surgery Partners from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Thursday, November 13th. Benchmark reaffirmed a “buy” rating on shares of Surgery Partners in a research note on Tuesday. Barclays reduced their price objective on shares of Surgery Partners from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Tuesday, March 3rd. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Surgery Partners in a research note on Monday, December 29th. Nine research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $24.45.

Surgery Partners Stock Performance

NASDAQ SGRY opened at $13.36 on Thursday. The business’s 50 day moving average is $15.20 and its two-hundred day moving average is $18.11. Surgery Partners has a 12-month low of $12.25 and a 12-month high of $24.64. The stock has a market capitalization of $1.73 billion, a price-to-earnings ratio of -21.55 and a beta of 1.95. The company has a current ratio of 1.87, a quick ratio of 1.72 and a debt-to-equity ratio of 1.15.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Monday, March 2nd. The company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.19). Surgery Partners had a negative net margin of 2.35% and a positive return on equity of 1.28%. The business had revenue of $885.00 million during the quarter, compared to analyst estimates of $866.54 million. During the same period last year, the business posted $0.44 EPS. Surgery Partners’s revenue was up 2.4% compared to the same quarter last year. Research analysts expect that Surgery Partners will post 0.67 EPS for the current year.

Surgery Partners declared that its Board of Directors has approved a share buyback program on Thursday, February 26th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the company to buy up to 9.7% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s board of directors believes its stock is undervalued.

Hedge Funds Weigh In On Surgery Partners

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. State of Wisconsin Investment Board boosted its position in Surgery Partners by 0.4% in the 4th quarter. State of Wisconsin Investment Board now owns 151,504 shares of the company’s stock valued at $2,341,000 after buying an additional 668 shares during the last quarter. ProShare Advisors LLC lifted its position in shares of Surgery Partners by 6.9% during the fourth quarter. ProShare Advisors LLC now owns 14,135 shares of the company’s stock worth $218,000 after purchasing an additional 909 shares during the last quarter. Jones Financial Companies Lllp lifted its position in shares of Surgery Partners by 313.1% during the third quarter. Jones Financial Companies Lllp now owns 1,227 shares of the company’s stock worth $27,000 after purchasing an additional 930 shares during the last quarter. AlphaQuest LLC grew its position in shares of Surgery Partners by 94.4% in the 2nd quarter. AlphaQuest LLC now owns 2,057 shares of the company’s stock worth $46,000 after acquiring an additional 999 shares in the last quarter. Finally, California State Teachers Retirement System raised its position in shares of Surgery Partners by 1.6% during the 2nd quarter. California State Teachers Retirement System now owns 65,091 shares of the company’s stock valued at $1,447,000 after acquiring an additional 1,021 shares in the last quarter.

More Surgery Partners News

Here are the key news stories impacting Surgery Partners this week:

• Positive Sentiment: Several analysts maintained buy/outperform ratings despite lowering targets, signaling continued conviction in recovery potential. Analyst Expectations For Surgery Partners’s Future
• Positive Sentiment: TD Cowen cut its price target to $20 but kept a “buy” rating, implying substantial upside from current levels if company execution improves. TD Cowen lowers PT to $20, keeps Buy
• Positive Sentiment: UBS trimmed its target to $21 while retaining a “buy” stance, another signal that analysts still see medium‑term upside despite near‑term weakness. UBS lowers PT to $21, keeps Buy
• Neutral Sentiment: Some commentary frames the current slump as a potential buying opportunity for long‑term investors, but emphasizes execution and margin recovery are key. Has Surgery Partners Slump Opened A New Opportunity For Investors?
• Negative Sentiment: Barclays cut its price target sharply to $14, signaling more conservative near‑term expectations and adding downward pressure on the stock. Barclays Lowers Surgery Partners Price Target to $14
• Negative Sentiment: Q4 results: revenue modestly beat, but EPS missed expectations and management flagged margin pressure — the core reason for the selloff and heightened execution risk. SGRY Q4 2025 Earnings Call Highlights
• Negative Sentiment: Shares hit a new 52‑week low after the earnings miss and analyst downgrades, reflecting elevated near‑term downside and investor concern about margin recovery. Surgery Partners Sets New 52-Week Low on Disappointing Earnings

About Surgery Partners

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.